Customereye

Eyebou (Visioneboutique)

Healthcare & Medical • United Kingdomvisioneboutique.com

Review data last updated .

Request Custom AnalysisSign up free to see everything

Based on public reviews and response behavior.

Tip: Tap or click the ⓘ icons to learn how to read each section. Expand cards for evidence.

Overall Score

54/100
4.57 ★ average rating · 600 reviews

Competitive Performance Rank

Among fully-analyzed Healthcare & Medical companies

#311of 615
Top 51% · Mid Pack
#1 (best)#615 (worst)
#309Peer
#310Peer
#311This company
#312Peer
#313Peer

Overall Customer Sentiment

Mid Pack

86% of reviews positive, 13% negative

86%
positive
  • Positive86%
  • Neutral2%
  • Negative13%

Sentiment Balance

Covering May 2021 — 4 reviews, not the company's full review history.

—
positive
  • Positive—
  • Neutral—
  • Negative—

Takeaway: Positive sentiment accounts for 50% of reviews in this period, with 50% negative and 0% neutral.

Sentiment Trend Over Time

Reviews (Count)

Showing 591 reviews across the months with enough data to chart reliably (min 3/month), most recent: May 2021.

Sentiment has been holding steady over the period shown.

Theme Distribution

Share of theme mentions

Delivery Shipping
21.9%
Product Quality
17.0%
Response Speed
15.7%
Customer Support
14.4%
Loyalty
9.9%

Most feedback concerns Delivery Shipping.

Churn Signal Score

Rule-based: negative-review share, churn-intent phrases, and sentiment movement over time.

MEDIUM32/100
32/100
signal score
  • •Built from a negative-review share of 29.7% across this company's analyzed reviews.
  • •1 review contain phrases that signal intent to leave, such as cancelling or switching provider.
  • •The share of negative reviews has held steady over time, so the trend doesn't move the score.

Reviewer Breakdown

Star split and recent-versus-earlier sentiment.

4.6avg rating
5★
81.2%
4★
7.8%
3★
3.2%
2★
2.5%
1★
5.3%

Based on 600 analyzed reviews. Sentiment is holding steady: 83.3% of reviews in the last three months were positive, compared with 80.0% in the three months before that.

Unlock full insights

Sign up to view detailed data and analysis